Innova Captab Limited (INNOVACAP.NS)
INR 875.7
(5.21%)
INR 875.7
(5.21%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.44 Billion INR | -7.88% |
| 2022 | 1.56 Billion INR | 21.77% |
| 2021 | 1.28 Billion INR | 40.4% |
| 2020 | 914.45 Million INR | 0.0% |
| 2019 | - INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 1.46 Billion INR | 0.81% |
| 2023 FY | 1.44 Billion INR | -7.88% |
| 2023 Q4 | 1.44 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | 1.45 Billion INR | -7.1% |
| 2022 Q4 | 1.56 Billion INR | 0.0% |
| 2022 FY | 1.56 Billion INR | 21.77% |
| 2021 FY | 1.28 Billion INR | 40.4% |
| 2020 FY | 914.45 Million INR | 0.0% |
| 2019 FY | - INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 91.237% |
| Hester Biosciences Limited | 755.81 Million INR | -90.545% |
| Aarti Drugs Limited | 4.85 Billion INR | 70.36% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 77.598% |
| Albert David Limited | 436.12 Million INR | -230.22% |
| Alembic Limited | 113.4 Million INR | -1169.982% |
| Alkem Laboratories Limited | 26.61 Billion INR | 94.588% |
| Bafna Pharmaceuticals Limited | 296.41 Million INR | -385.854% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 0.015% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -5548.351% |
| Brooks Laboratories Limited | 96.1 Million INR | -1398.481% |
| Eris Lifesciences Limited | 1.89 Billion INR | 23.814% |
| FDC Limited | 3.88 Billion INR | 62.967% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 78.395% |
| Gufic Biosciences Limited | 2 Billion INR | 28.165% |
| Hikal Limited | 3.03 Billion INR | 52.583% |
| Ind-Swift Limited | 640.91 Million INR | -124.704% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 66.101% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -860.299% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 88.833% |
| Lincoln Pharmaceuticals Limited | 771.68 Million INR | -86.626% |
| Lupin Limited | 49.53 Billion INR | 97.093% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -16.48% |
| Medico Remedies Limited | 163.37 Million INR | -781.522% |
| Morepen Laboratories Limited | 2.48 Billion INR | 42.068% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 79.692% |
| Orchid Pharma Limited | 2.64 Billion INR | 45.495% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -31.992% |
| RPG Life Sciences Limited | 1.01 Billion INR | -42.59% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -3511.234% |
| Sigachi Industries Limited | 707.2 Million INR | -103.641% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 59.962% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 37.708% |
| Themis Medicare Limited | 705.74 Million INR | -104.063% |
| Unichem Laboratories Limited | 7.04 Billion INR | 79.563% |
| Vaishali Pharma Limited | 3.79 Million INR | -37828.891% |
| Wanbury Limited | 360.23 Million INR | -299.787% |
| Windlas Biotech Limited | 621.89 Million INR | -131.578% |
| ZIM Laboratories Limited | 812.62 Million INR | -77.222% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -1277.129% |
| Ipca Laboratories Limited | 24.71 Billion INR | 94.172% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 98.541% |
| Venus Remedies Limited | 1.21 Billion INR | -18.347% |
| Sakar Healthcare Limited | 277.32 Million INR | -419.308% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 98.532% |
| Divi's Laboratories Limited | 31.84 Billion INR | 95.477% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 36.802% |
| Mankind Pharma Limited | 15.53 Billion INR | 90.729% |
| Sequent Scientific Limited | 3.46 Billion INR | 58.405% |
| Laurus Labs Limited | 18.45 Billion INR | 92.196% |
| Neuland Laboratories Limited | 3.5 Billion INR | 58.902% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 71.341% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 94.269% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 95.816% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -398.244% |
| Wockhardt Limited | 6.4 Billion INR | 77.498% |
| Bal Pharma Limited | 878.11 Million INR | -64.006% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 97.734% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -21.587% |
| Par Drugs and Chemicals Limited | 41.77 Million INR | -3347.833% |
| Caplin Point Laboratories Limited | 3.63 Billion INR | 60.331% |
| Shilpa Medicare Limited | 3.44 Billion INR | 58.248% |
| Valiant Laboratories Limited | 100.15 Million INR | -1337.946% |
| Ajanta Pharma Limited | 8.28 Billion INR | 82.614% |
| Aarey Drugs & Pharmaceuticals Limited | 346.75 Million INR | -315.322% |
| Granules India Limited | 13 Billion INR | 88.926% |
| Medicamen Biotech Limited | 593.75 Million INR | -142.552% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -583.139% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 93.681% |
| NATCO Pharma Limited | 7 Billion INR | 79.441% |
| Suven Life Sciences Limited | 7.08 Million INR | -20226.888% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -1370.091% |
| Strides Pharma Science Limited | 11.26 Billion INR | 87.213% |
| Indoco Remedies Limited | 3.53 Billion INR | 59.209% |
| Alpa Laboratories Limited | 136.65 Million INR | -953.881% |
| Lasa Supergenerics Limited | 190.43 Million INR | -656.252% |
| Sun Pharma Advanced Research Company Limited | 14.79 Million INR | -9636.074% |